Mode
Text Size
Log in / Sign up
Phase 3 N=34 Randomized Treatment

Strength Training in Walking Tolerance in Intermittent Claudication Patients

Peripheral Arterial Disease · Hypertension · Diabetes

Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Apr 2009
Primary outcome: Primary: Total Walking Distance — 618; 572 meter — p=<0.05

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Walking Training (Behavioral); Strength Training (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Sao Paulo
Primary completion
Aug 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Walking Distance
618; 572 <0.05 sig

Summary

Background: Muscle atrophy and reduced leg strength are related to exercise intolerance in patients with intermittent claudication (IC), suggesting that strength training (ST) could improve exercise performance in these patients. Objective: Analyze the effects of ST in walking capacity in patients with IC comparing with walking training (WT) effects. Intervention: Patients were randomized into ST and WT. Both groups trained twice a week, for 12 weeks, at the same rate of perceived exertion. ST consisted of 3 sets of 10 repetitions of whole body exercises. WT consisted of 15 two-minute bouts of walking intercalated with 2 minutes of resting. Measurements: Walking capacity, peak VO2, walking economy, ankle brachial index, ischemic window and knee extension strength

Eligibility Criteria

Inclusion Criteria

  • Fontaine stage II peripheral arterial disease(14)
  • Symptoms of intermittent claudication for at least 6 months
  • Ankle/brachial index (ABI) at rest ≤ 0.90 in 1 or 2 legs
  • Reduction of ABI after treadmill test
  • Exercise tolerance limited by intermittent claudication

Exclusion Criteria

  • Presence of chronic lung disease
  • Inability to obtain ABI measurement due to noncompressible vessels
  • Exercise tolerance limited by factors other than claudication (e.g., dyspnea or orthopedic problems)
  • Poorly controlled blood pressure
  • Presence of electrocardiogram response suggestive of myocardial ischemia during the exercise test
  • History of revascularization in the previous year
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00879697). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search